AZ vs PLTS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits extremely weak financial health with a Piotroski F-Score of just 1/9, indicating severe operational and profitability concerns. Despite strong short-term earnings surprises and a bullish analyst target price of $30.00, the firm remains deeply unprofitable with negative operating margins (-265.87%), negative ROE (-89.37%), and declining year-over-year revenue (-1.60%). High valuation multiples, including a Price/Sales ratio of 41.74, suggest the stock is pricing in aggressive future growth not supported by current fundamentals. While liquidity ratios are strong and debt is minimal, the lack of profitability and inconsistent earnings trajectory raise material sustainability concerns.
PLTS exhibits a critical disconnect between its market price ($17.50) and its fundamental value, with a Graham Number of $0.26 and an Intrinsic Value of $0.07. While the Piotroski F-Score of 4/9 suggests a stable financial baseline and the current ratio of 7.12 indicates strong short-term liquidity, these are overshadowed by catastrophic operating margins (-3250.49%) and a severe revenue collapse of -77.70% YoY. The stock is trading at an unsustainable P/E of 1750 and a Price/Sales ratio of 188.65, suggesting a purely speculative valuation unsupported by any growth or profitability metrics.
Compare Another Pair
Related Comparisons
AZ vs PLTS: Head-to-Head Comparison
This page compares A2Z Cust2Mate Solutions Corp. (AZ) and Platinum Analytics Cayman Limited (PLTS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.